Published in Lipids Health Dis on July 26, 2010
Minireview: mechanisms of growth hormone-mediated gene regulation. Mol Endocrinol (2014) 1.04
Association between serum growth hormone levels and nonalcoholic fatty liver disease: a cross-sectional study. PLoS One (2012) 0.91
Prenatal dexamethasone exposure potentiates diet-induced hepatosteatosis and decreases plasma IGF-I in a sex-specific fashion. Endocrinology (2011) 0.91
Protective effect of whey proteins against nonalcoholic fatty liver in rats. Lipids Health Dis (2011) 0.90
The intricate role of growth hormone in metabolism. Front Endocrinol (Lausanne) (2011) 0.89
Protective effects of total glucosides of paeony and the underlying mechanisms in carbon tetrachloride-induced experimental liver injury. Arch Med Sci (2011) 0.88
G-protein-coupled bile acid receptor plays a key role in bile acid metabolism and fasting-induced hepatic steatosis in mice. Hepatology (2016) 0.81
Exploring the molecular mechanisms underlying the potentiation of exogenous growth hormone on alcohol-induced fatty liver diseases in mice. J Transl Med (2010) 0.80
Growth Hormone Inhibits Hepatic De Novo Lipogenesis in Adult Mice. Diabetes (2015) 0.79
Growth Hormone Control of Hepatic Lipid Metabolism. Diabetes (2016) 0.79
Hepatic PPARγ Is Not Essential for the Rapid Development of Steatosis After Loss of Hepatic GH Signaling, in Adult Male Mice. Endocrinology (2016) 0.77
The Association Between IGF-1 Levels and the Histologic Severity of Nonalcoholic Fatty Liver Disease. Clin Transl Gastroenterol (2017) 0.75
Co-administration of metformin and N-acetylcysteine with dietary control improves the biochemical and histological manifestations in rats with non-alcoholic fatty liver. Res Pharm Sci (2016) 0.75
Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia (1985) 109.13
Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction. Anal Biochem (1979) 41.65
Nonalcoholic fatty liver disease. N Engl J Med (2002) 22.41
Nonalcoholic steatohepatitis: a proposal for grading and staging the histological lesions. Am J Gastroenterol (1999) 14.07
Steatohepatitis: a tale of two "hits"? Gastroenterology (1998) 13.21
Protection from obesity-induced insulin resistance in mice lacking TNF-alpha function. Nature (1997) 10.53
Expanding the natural history of nonalcoholic steatohepatitis: from cryptogenic cirrhosis to hepatocellular carcinoma. Gastroenterology (2002) 6.62
The fat-derived hormone adiponectin alleviates alcoholic and nonalcoholic fatty liver diseases in mice. J Clin Invest (2003) 5.32
Cytokines in alcoholic and nonalcoholic steatohepatitis. N Engl J Med (2000) 3.47
Liver enzyme alteration: a guide for clinicians. CMAJ (2005) 3.42
Leptin receptor-mediated signaling regulates hepatic fibrogenesis and remodeling of extracellular matrix in the rat. Gastroenterology (2002) 2.97
Ninety patients with nonalcoholic steatohepatitis: insulin resistance, familial tendency, and severity of disease. Am J Gastroenterol (2001) 2.81
Gene expression of tumor necrosis factor alpha and TNF-receptors, p55 and p75, in nonalcoholic steatohepatitis patients. Hepatology (2001) 2.69
A prospective analysis of the HOMA model. The Mexico City Diabetes Study. Diabetes Care (1996) 2.35
PPARalpha: energy combustion, hypolipidemia, inflammation and cancer. Nucl Recept Signal (2010) 2.08
Fatty infiltration of liver in hyperlipidemic patients. Dig Dis Sci (2000) 1.85
Signaling pathways activated by the growth hormone receptor. Trends Endocrinol Metab (2001) 1.73
Liver-specific deletion of the growth hormone receptor reveals essential role of growth hormone signaling in hepatic lipid metabolism. J Biol Chem (2009) 1.69
The long-term effects of the lipid-lowering agent fenofibrate in hyperlipidemic heart transplant recipients. Transplantation (1994) 1.45
A novel leptin receptor isoform in rat. FEBS Lett (1996) 1.40
Resveratrol improves non-alcoholic fatty liver disease by activating AMP-activated protein kinase. Acta Pharmacol Sin (2008) 1.38
Resveratrol inhibits nonalcoholic fatty liver disease in rats. BMC Gastroenterol (2008) 1.37
Increased lipid peroxidation and impaired antioxidant enzyme function is associated with pathological liver injury in experimental alcoholic liver disease in rats fed diets high in corn oil and fish oil. Hepatology (1998) 1.35
Bacterial translocation in cirrhotic rats stimulates eNOS-derived NO production and impairs mesenteric vascular contractility. J Clin Invest (1999) 1.24
The role of leptin in progression of non-alcoholic fatty liver disease. Hepatol Res (2005) 1.23
Effects of recombinant human growth hormone on hepatic lipid and carbohydrate metabolism in HIV-infected patients with fat accumulation. J Clin Endocrinol Metab (2002) 1.20
Resistin as an intrahepatic cytokine: overexpression during chronic injury and induction of proinflammatory actions in hepatic stellate cells. Am J Pathol (2006) 1.14
Growth hormone reverses nonalcoholic steatohepatitis in a patient with adult growth hormone deficiency. Gastroenterology (2006) 1.13
Infliximab reverses steatosis and improves insulin signal transduction in liver of rats fed a high-fat diet. J Endocrinol (2007) 1.13
How growth hormone controls growth, obesity and sexual dimorphism. Trends Genet (2007) 1.04
Dietary saponins of sea cucumber alleviate orotic acid-induced fatty liver in rats via PPARalpha and SREBP-1c signaling. Lipids Health Dis (2010) 1.03
Correlation of abdominal fat accumulation and liver steatosis: importance of ultrasonographic and anthropometric measurements. Eur J Ultrasound (2001) 1.02
Resistin is expressed in different rat tissues and is regulated in a tissue- and gender-specific manner. FEBS Lett (2003) 1.02
Role of growth hormone, insulin-like growth factor 1 and insulin-like growth factor-binding protein 3 in development of non-alcoholic fatty liver disease. Hepatol Int (2007) 1.01
Effects of a physiological GH pulse on interstitial glycerol in abdominal and femoral adipose tissue. Am J Physiol (1999) 1.01
Nonalcoholic steatohepatitis and the metabolic syndrome. Metab Syndr Relat Disord (2008) 0.98
Comparative toxicity and safety profile of fenofibrate and other fibric acid derivatives. Am J Med (1987) 0.97
Effects of fenofibrate and xuezhikang on high-fat diet-induced non-alcoholic fatty liver disease. Clin Exp Pharmacol Physiol (2007) 0.97
Antisense protein tyrosine phosphatase 1B reverses activation of p38 mitogen-activated protein kinase in liver of ob/ob mice. Mol Endocrinol (2003) 0.95
Effects of growth hormone (GH) on ghrelin, leptin, and adiponectin in GH-deficient patients. J Clin Endocrinol Metab (2003) 0.93
GH treatment in adults with chronic liver disease: a randomized, double-blind, placebo-controlled, cross-over study. J Clin Endocrinol Metab (2002) 0.93
Leptin and leptin receptors in the prostate and seminal vesicles of the adult rat. Int J Mol Med (2006) 0.91
Effect of growth hormone on fatty liver in panhypopituitarism. Arch Dis Child (1997) 0.89
Growth hormone inhibits lipoprotein lipase activity in human adipose tissue. J Clin Endocrinol Metab (1995) 0.86
TNF-alpha in the development of insulin resistance and other disorders in metabolic syndrome. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub (2005) 0.86
Glutathione deficiency down-regulates hepatic lipogenesis in rats. Lipids Health Dis (2010) 0.86
Real-time PCR analysis of leptin and leptin receptor expression in the rat prostate, and effects of leptin on prostatic acid phosphatase release. Int J Mol Med (2006) 0.85
Growth hormone rapidly induces resistin gene expression in white adipose tissue of spontaneous dwarf (SDR) rats. Endocrinology (2002) 0.85
Superior neovascularization and muscle regeneration in ischemic skeletal muscles following VEGF gene transfer by rAAV1 pseudotyped vectors. Biochem Biophys Res Commun (2005) 0.83
Growth hormone regulates leptin gene expression in bovine adipose tissue: correlation with adipose IGF-1 expression. J Endocrinol (2000) 0.82
A microarray gene analysis of peripheral whole blood in normal adult male rats after long-term GH gene therapy. Cell Mol Biol Lett (2010) 0.82
Hepatic adiponectin receptor R2 expression is up-regulated in normal adult male mice by chronic exogenous growth hormone levels. Mol Med Rep (2011) 0.81
Inhibition of JNK along with activation of ERK1/2 MAPK pathways improve steatohepatitis among the rats. Clin Nutr (2009) 0.80
Increase of fat oxidation and weight loss in obese mice caused by chronic treatment with human growth hormone or a modified C-terminal fragment. Int J Obes Relat Metab Disord (2001) 0.80
Assessment of lipid peroxidation and antioxidant capacity in non-alcoholic fatty liver disease. Turk J Gastroenterol (2005) 0.77
[Exercise-induced changes of T lymphocytes subgroups and immune factors]. Nan Fang Yi Ke Da Xue Xue Bao (2010) 0.81
Exploring the molecular mechanisms underlying the potentiation of exogenous growth hormone on alcohol-induced fatty liver diseases in mice. J Transl Med (2010) 0.80
[Anti-mutagenesis effects of total flavonoids of Astragalus]. Zhongguo Zhong Yao Za Zhi (2003) 0.79
Genes expression profiling of peripheral blood cells of patients with hepatocellular carcinoma. Cell Biol Int (2012) 0.79
Biochemical characteristics and risk factors in non-alcoholic fatty liver. Front Biosci (Elite Ed) (2010) 0.78
Prognostic value of combined serum biomarkers in predicting outcomes in cervical cancer patients. Clin Chim Acta (2013) 0.78
[hTERT single nucleotide polymorphism is associated with increased risks of hepatocellular carcinoma and tumor metastasis]. Nan Fang Yi Ke Da Xue Xue Bao (2011) 0.77
Isolation and characterization of urethanase from Penicillium variabile and its application to reduce ethyl carbamate contamination in Chinese rice wine. Appl Biochem Biotechnol (2013) 0.77
Clinical utility of serum tumor markers and cytokines in cervical cancer and neoplasia. Clin Chem Lab Med (2013) 0.77
[Studies of bi-derectional modulation effect of kudzuvine root on immunol cells]. Zhongguo Zhong Yao Za Zhi (2002) 0.75
Purification, properties, and application of a novel acid urease from Enterobacter sp. Appl Biochem Biotechnol (2008) 0.75
Purification and characterization of a urethanase from Penicillium variabile. Appl Biochem Biotechnol (2014) 0.75
[Feasibility of peptide mass fingerprinting for differential diagnosis of IgA and non-IgA nephropathy]. Nan Fang Yi Ke Da Xue Xue Bao (2011) 0.75
[The study on metabolic difference of human body affected by active stress and passive stress under special events]. Nan Fang Yi Ke Da Xue Xue Bao (2010) 0.75
A new method of screening human papillomavirus genotypes and clinical validation. Front Biosci (Elite Ed) (2010) 0.75
[A preliminary report of SARS coronavirus specific RNA in SARS convalescents and medical person]. Zhongguo Wei Zhong Bing Ji Jiu Yi Xue (2004) 0.75